- Home
- HOUR vs QNCX Comparison
HOUR vs QNCX Comparison
Compare HOUR & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- QNCX
- Stock Information
- Founded
- HOUR 2015
- QNCX 2012
- Country
- HOUR United States
- QNCX United States
- Employees
- HOUR N/A
- QNCX N/A
- Industry
- HOUR Catalog/Specialty Distribution
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOUR Consumer Discretionary
- QNCX Health Care
- Exchange
- HOUR Nasdaq
- QNCX Nasdaq
- Market Cap
- HOUR 43.2M
- QNCX 43.2M
- IPO Year
- HOUR 2022
- QNCX 2019
- Fundamental
- Price
- HOUR $1.29
- QNCX $1.20
- Analyst Decision
- HOUR
- QNCX Strong Buy
- Analyst Count
- HOUR 0
- QNCX 5
- Target Price
- HOUR N/A
- QNCX $8.00
- AVG Volume (30 Days)
- HOUR 24.8K
- QNCX 283.1K
- Earning Date
- HOUR 06-13-2025
- QNCX 05-13-2025
- Dividend Yield
- HOUR N/A
- QNCX N/A
- EPS Growth
- HOUR N/A
- QNCX N/A
- EPS
- HOUR 0.01
- QNCX N/A
- Revenue
- HOUR $139,408,829.00
- QNCX N/A
- Revenue This Year
- HOUR N/A
- QNCX N/A
- Revenue Next Year
- HOUR N/A
- QNCX N/A
- P/E Ratio
- HOUR $186.13
- QNCX N/A
- Revenue Growth
- HOUR 2.71
- QNCX N/A
- 52 Week Low
- HOUR $0.83
- QNCX $0.51
- 52 Week High
- HOUR $6.90
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- HOUR 46.39
- QNCX 55.74
- Support Level
- HOUR $1.22
- QNCX $1.01
- Resistance Level
- HOUR $1.34
- QNCX $1.06
- Average True Range (ATR)
- HOUR 0.08
- QNCX 0.09
- MACD
- HOUR 0.00
- QNCX 0.02
- Stochastic Oscillator
- HOUR 26.43
- QNCX 90.20
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.